2 | 2017 Facility of the Year Awards
Facility of the Year Awards 2017
Any reproduction of the contents of this supplement
in whole or part is strictly forbidden without the
written permission of ISPE. Views and conclusions
expressed in articles herein are those of the authors
and not necessarily those of the editorial staff,
officials, and Board of Directors of ISPE.
©2017 International Society for Pharmaceutical
Engineering. The ISPE logo and Facility of the Year
Awards are registered trademarks.
7200 Wisconsin Ave., Suite 305
Bethesda, MD 20817, US
ISPE Operations and Training Center
600 N. Westshore Blvd., Suite 900
Tampa, Florida 33609, US
ISPE is an association rooted in the tradition of collaboration and
knowledge sharing. It is our reason for being, and the reason our
members join. We provide members with opportunities not only to
learn from one another, we also make it possible for them to shape
that learning to further pharmaceutical manufacturing innovation.
Since the first publication almost four decades ago, ISPE Guidance
Documents have played a fundamental role in that learning process.
The collective knowledge of the pharmaceutical manufacturing
industry professionals who write them—on topics as diverse as
biopharmaceutical process development and data integrity—
encourages innovation, furthers technological advances, and
facilitates regulatory compliance. Hundreds of members have
collaborated, debated, and discussed to write Guidance Documents
for their colleagues. They do it selflessly, and with the humility that
makes the knowledge they share so well received by their peers.
Does this knowledge seep into the processes and mindsets that
create award-winning FOYA submissions? Does it foster innovative
thinking and imagination? I will leave that for you to judge as you
read through this year’s winning submissions. What is certain, from
ISPE’S perspective, is that FOYA projects are a testament to the role
innovation and excellence play in pharmaceutical manufacturing.
Cheers, then, to FOYA Category Winners Abbott (Operational
Excellence), Bristol-Myers Squibb (Facility Integration), Cook
Pharmica (Equipment Innovation), Eli Lilly and Company (Process
Innovation and Facility of the Future), Jazz Pharmaceuticals (Project
Execution), and Honorable Mentions Nephron Pharmaceuticals
Corporation, Novartis-Penn Center for Advanced Cellular Therapies,
and PT. Kalbio Global Medika.
John E. Bournas
ISPE CEO and President